Eli Lilly Healthcare Conference 2024 JPMorgan

Eli Lilly CEO Dave Ricks presents long-term performance driven by innovation focus and obesity treatment market expansion at the J.P. Morgan Healthcare Conference. Stock performance reached +653% from January 2018 to December 2023, significantly outpacing the broader drug sector index.